These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 8725190

  • 21. In vivo measurements of relaxivities in the rat kidney cortex.
    Pedersen M, Mørkenborg J, Jensen FT, Stødkilde-Jørgensen H, Djurhuus JC, Frokiaer J.
    J Magn Reson Imaging; 2000 Aug; 12(2):289-96. PubMed ID: 10931592
    [Abstract] [Full Text] [Related]

  • 22. Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA.
    Kim T, Murakami T, Hasuike Y, Gotoh M, Kato N, Takahashi M, Miyazawa T, Narumi Y, Monden M, Nakamura H.
    J Magn Reson Imaging; 1997 Aug; 7(4):683-8. PubMed ID: 9243389
    [Abstract] [Full Text] [Related]

  • 23. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.
    Hamm B, Staks T, Mühler A, Bollow M, Taupitz M, Frenzel T, Wolf KJ, Weinmann HJ, Lange L.
    Radiology; 1995 Jun; 195(3):785-92. PubMed ID: 7754011
    [Abstract] [Full Text] [Related]

  • 24. Comparison of Gd-EOB-DTPA and Gd-DTPA for contrast-enhanced MR imaging of liver tumors.
    Clemént O, Mühler A, Vexler VS, Kuwatsuru R, Berthezène Y, Rosenau W, Brasch RC.
    J Magn Reson Imaging; 1993 Jun; 3(1):71-7. PubMed ID: 8428104
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid.
    Jia J, Puls D, Oswald S, Jedlitschky G, Kühn JP, Weitschies W, Hosten N, Siegmund W, Keiser M.
    Invest Radiol; 2014 Feb; 49(2):78-86. PubMed ID: 24056116
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Biliary excretion and pharmacokinetics of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging in the rat.
    Schuhmann-Giampieri G, Schmitt-Willich H, Frenzel T, Schitt-Willich H [corrected to Schmitt-Willich H].
    J Pharm Sci; 1993 Aug; 82(8):799-803. PubMed ID: 8377117
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
    Mühler A, Clément O, Vexler V, Berthezène Y, Rosenau W, Brasch RC.
    Radiology; 1992 Jul; 184(1):207-13. PubMed ID: 1609081
    [Abstract] [Full Text] [Related]

  • 36. Kinetics and magnetic resonance imaging of Gd-EOB-DTPA in dogs.
    Benness G, Khangure M, Morris I, Warwick A, Burrows P, Vogler H.
    Invest Radiol; 1994 Jun; 29 Suppl 2():S177-8. PubMed ID: 7928221
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
    Reimer P, Rummeny EJ, Shamsi K, Balzer T, Daldrup HE, Tombach B, Hesse T, Berns T, Peters PE.
    Radiology; 1996 Apr; 199(1):177-83. PubMed ID: 8633143
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.